From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves Biogen Idec's multiple sclerosis drug

from The Boston Globe

Scrambling to stay ahead of the competition in bringing multiple sclerosis drugs to market, Biogen Idec Inc. won U.S. regulatory approval to sell a new type of injectable drug that treats adults with the most common form of the neurodegenerative disease. Food and Drug Administration regulators approved the Cambridge biotech’s application to market the drug, called Plegridy, as a longer-lasting treatment for U.S. patients with relapsing-remitting multiple sclerosis. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063